Results 11 to 20 of about 879,459 (400)

Compliance to the secondary prophylaxis and awareness of rheumatic heart disease: A cross-sectional study in low-income province of India

Journal of Family Medicine and Primary Care, 2020
Background: Rheumatic heart disease is a preventable problem and regular secondary prophylaxis and proper awareness about this disease among common people may reduce the burden of this disease in any region.
Arun Prasad, Abhiranjan Prasad, Birendra K Singh, Sanjeev Kumar   +3 more
doaj   +2 more sources

Genetics of rheumatic fever and rheumatic heart disease

Nature Reviews Cardiology, 2019
Rheumatic heart disease (RHD) is a complication of group A streptococcal infection that results from a complex interaction between the genetic make-up of the host, the infection itself and several other environmental factors, largely reflecting poverty.
Karen Sliwa, Tom Parks, Tom Parks, Babu Muhamed   +3 more
openaire   +7 more sources

Rheumatic Heart Disease: A Global Call to Action. [PDF]

JACC Case Rep
Moe TG.
europepmc   +2 more sources

Rivaroxaban in Rheumatic Heart Disease-Associated Atrial Fibrillation.

New England Journal of Medicine, 2022
BACKGROUND Testing of factor Xa inhibitors for the prevention of cardiovascular events in patients with rheumatic heart disease-associated atrial fibrillation has been limited.
S. Connolly, G. Karthikeyan, M. Ntsekhe, A. Haileamlak, Ahmed El Sayed, A. El Ghamrawy, A. Damasceno, Á. Avezum, A. Dans, B. Gitura, D. Hu, Emmanuel R Kamanzi, F. Maklady, G. Fana, J. González-Hermosillo, J. Musuku, K. Kazmi, L. Zühlke, Lillian Gondwe, Changsheng Ma, M. Paniagua, O. Ogah, O. J. Molefe-Baikai, P. Lwabi, P. Chillo, Sanjib K Sharma, T. T. Cabral, W. Tarhuni, A. Benz, Martin van Eikels, Amy Krol, Divya Pattath, K. Balasubramanian, S. Rangarajan, C. Ramasundarahettige, B. Mayosi, S. Yusuf   +36 more
semanticscholar   +1 more source

Global burden of rheumatic heart disease: trends from 1990 to 2019

Arthritis Research & Therapy, 2022
Background Rheumatic heart disease (RHD) is a critical public health issue worldwide, and its epidemiological patterns have changed over the decades.
Ze-jin Ou, Danfeng Yu, Yuanhao Liang, Jinhua Wu, Huan He, Yong-zhi Li, Wen-qiao He, Yu-han Gao, Fei Wu, Qing Chen   +9 more
semanticscholar   +1 more source

Rheumatic Heart Disease Is a Neglected Disease Relative to Its Burden Worldwide: Findings From Global Burden of Disease 2019

Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease, 2022
Background Rheumatic heart disease (RHD) takes a heavy toll in low‐ and middle‐income countries. We aimed to present worldwide estimates for the burden of the RHD during 1990 to 2019 using the GBD (Global Burden of Disease) study.
S. Ghamari, M. Abbasi-Kangevari, Sahar Saeedi Moghaddam, Arya Aminorroaya, N. Rezaei, Parnian Shobeiri, Zahra Esfahani, Mohammad-Reza Malekpour, N. Rezaei, A. Ghanbari, M. Keykhaei, Mohammadreza Naderian, B. Larijani, Mohamad Taghi Majnoon, F. Farzadfar, A. Mokdad   +15 more
semanticscholar   +1 more source

Recent Advances in the Rheumatic Fever and Rheumatic Heart Disease Continuum

Pathogens, 2022
Nearly a century after rheumatic fever (RF) and rheumatic heart disease (RHD) was eradicated from the developed world, the disease remains endemic in many low- and middle-income countries (LMICs), with grim health and socioeconomic impacts.
Joselyn Rwebembera, B. Nascimento, Neema W Minja, Sarah R. de Loizaga, T. Aliku, Luiza Pereira Afonso dos Santos, B. Galdino, Luiza Silame Corte, V. R. Silva, A. Chang, W. Dutra, M. C. Nunes, A. Beaton   +12 more
semanticscholar   +1 more source

Acute Rheumatic Fever and Rheumatic Heart Disease: Highlighting the Role of Group A Streptococcus in the Global Burden of Cardiovascular Disease

Pathogens, 2022
Group A Streptococcus (GAS) causes superficial and invasive infections and immune mediated post-infectious sequalae (including acute rheumatic fever/rheumatic heart disease).
T. Auala, Ben’Lauro Goncalves Zavale, A. Mbakwem, A. Mocumbi   +3 more
semanticscholar   +1 more source

Therapeutics for rheumatic fever and rheumatic heart disease

Australian Prescriber, 2022
SUMMARY The goals of acute rheumatic fever therapy are to relieve symptoms, mitigate cardiac valve damage and eradicate streptococcal infection. Preventing future recurrences requires long-term secondary antibiotic prophylaxis and ongoing prevention of ...
A. Ralph, B. Currie
semanticscholar   +1 more source

Secondary Antibiotic Prophylaxis for Latent Rheumatic Heart Disease.

New England Journal of Medicine, 2021
BACKGROUND Rheumatic heart disease affects more than 40.5 million people worldwide and results in 306,000 deaths annually. Echocardiographic screening detects rheumatic heart disease at an early, latent stage.
A. Beaton, E. Okello, Joselyn Rwebembera, A. Grobler, Daniel Engelman, Juliet Alepere, Lesley Canales, J. Carapetis, A. DeWyer, P. Lwabi, M. Mirabel, A. Mocumbi, M. Murali, M. Nakitto, E. Ndagire, M. C. Nunes, I. Omara, R. Sarnacki, Amy Scheel, N. Wilson, M. Zimmerman, L. Zühlke, G. Karthikeyan, C. Sable, A. Steer   +24 more
semanticscholar   +1 more source